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ABSTRACT 
 
Introduction: Endometriosis is a gynecological disorder that may cause considerable pelvic 
pain in women of fertile age. Determining pain mechanisms is necessary in order to optimize 
the treatment of the disease. The objective of the study was to evaluate pain thresholds in 
women with persistent pelvic pain with and without confirmed endometriosis, and healthy, 
unaffected controls, and analyze how pain thresholds in these cohorts related to duration of 
pelvic pain, quality of life, and symptoms of anxiety and depression. Material and methods: 
Pain thresholds for heat, cold, and pressure were assessed with quantitative sensory testing on 
six locations on a reference group of 55 healthy women and on 37 women with persistent 
pelvic pain who had been admitted for diagnostic laparoscopy on the suspicion of 
endometriosis. Validated instruments were applied to assess quality of life and symptoms of 
anxiety and depression. Data were analyzed by means of uni- and multivariate analysis of 
variance and Spearman’s rank-order correlation. Results: The women with persistent pelvic 
pain had significantly lower pain thresholds compared with the reference women. No 
differences were observed in pain thresholds between the women with pain, with (13 women) 
and without (24 women) biopsy-proven endometriosis. The duration of pelvic pain correlated 
significantly positively to reduced pain thresholds i.e. the longer the duration, the more 
sensitization. In the persistent pelvic pain group, pain thresholds for heat correlated 
significantly with the Short Form Health Survey 36 (SF-36) dimension of bodily pain, while 
thresholds for cold correlated with SF-36 bodily pain and with symptoms of depression. 
Conclusion: Our results showed widespread alterations in pain thresholds in women with 
persistent pelvic pain that are indicative of central sensitization and a time-dependent 
correlation. Women with pelvic pain and suspicion of endometriosis should probably be 
treated more thoroughly in order to prevent or at least minimize the concomitant development 
of central sensitization. 
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Abbreviations 
CS  central sensitization  
HADS Hospital Anxiety and Depression Scale 
PPP  persistent pelvic pain 
QoL  quality of life  
R   Spearman’s rho 
SF-36  Short Form Health Survey 36   
 
Key Message 
Women with persistent pelvic pain and symptoms indicating endometriosis show 
significantly reduced pain thresholds compared with healthy women, which is indicative of 
central sensitization.  
 
INTRODUCTION 
 
Endometriosis is an estrogen-dependent disease associated with persistent pelvic pain (PPP) 
1,2
. The precise mechanisms of endometriosis-associated pelvic pain remain poorly 
understood but a combination of nociceptive, inflammatory, angiogenetic, neurovascular and 
neuropathic mechanisms seems to be involved 
3
. The pain often reduces quality of life (QoL) 
and is associated with reduced physical and mental wellbeing 
4–7
. 
Persons with persistent pain states often show widespread reduced pain thresholds, 
which are considered as proxies for central sensitization (CS). CS is defined in animal models 
as dorsal horn neurons that give hyperactive responses to various sensory inputs. The dorsal 
horns cannot be examined in the same way in humans. Therefore, widespread reduced pain 
thresholds to a given stimulus are used as a proxy 
8
. A few studies have indicated that women 
with endometriosis-associated pain might have widespread reduced pain thresholds and CS 
9–
13
, but more research on the subject is warranted to determine the pain mechanisms in order 
to optimize the treatment of the disease.  
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Previous studies of chronic pain have shown that the history and duration of pain are 
crucial factors for driving sensitization 
8
 but so far, this has not been addressed for patients 
with PPP.  
The objective of this study was to evaluate pain thresholds in women with PPP with 
and without confirmed endometriosis, and healthy, unaffected women, and analyze how pain 
thresholds in these cohorts related to duration of pelvic pain, QoL, and symptoms of anxiety 
and depression. 
 
MATERIAL AND METHODS 
 
We conducted this cross-sectional observational comparative exploratory study between 
December 2013 and June 2016. Eligible for the study were women 18-40 years of age who 
had PPP and had been admitted to the Department of Obstetrics and Gynecology at a central 
hospital and a university hospital in southeast Sweden for diagnostic laparoscopy on 
suspicion of endometriosis. PPP was defined as self-reported moderate or severe pelvic pain 
for a period of four months or longer 
14
.  
Exclusion criteria were a previously surgically verified diagnosis of endometriosis or 
by history any other diagnosed chronic pain syndrome such as fibromyalgia, chronic 
headache, arthritis or other joint problems, nerve damages or rhizopathia, mental illness with 
anti-depressive medication or mental disability, and on-going substance abuse. Pregnant or 
breast-feeding women were also excluded, as were women who did not speak or understand 
Swedish. 
The administrative nurse in charge of the waiting list for surgery in the departments 
assessed all referral letters. Forty-six women fulfilled the criteria and were found eligible to 
participate. They were contacted by phone by the first author, who provided them with 
detailed verbal and written information about the study. Of these women, 40 agreed to 
participate, but three did not come to the scheduled appointment, leaving 37 participants. 
Written informed consent was obtained from all participants before inclusion. During and 
after the laparoscopy the women with PPP were treated surgically and/or pharmaceutically 
with hormonal therapies and/or analgesics in accordance with the clinical routines. The extent 
of the endometriosis was categorized according to the revised American Society for 
Reproductive Medicine score in minimal, mild, moderate and severe 
15
. 
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A group of 55 healthy women aged 18 – 40 years without a history of pelvic pain or 
other symptoms that might indicate endometriosis, or any other chronic pain syndrome 
served as a reference group. The women in the reference group were recruited through local 
advertisements at the hospitals and the university affiliated to the clinics. None of these 
women used any medication that could have any known effect on pain thresholds, but some 
of them used hormonal contraceptives. In an attempt to minimize the influence of menstrual 
cycle variability on the pain thresholds, the experimental sessions were conducted between 
days 1-7 of the cycle in women who were not using hormonal contraceptives 
16,17
.  
Data concerning demographics and medical and surgical history, including current 
medication, were collected at inclusion in the study. Pain thresholds for cold, heat and 
pressure were measured within four weeks prior to the planned surgery. The participants 
were asked to refrain from analgesics before the pain threshold measurements on the day of 
assessment. 
At the visit for the pain threshold measurements, all participants completed three 
questionnaires; two assessing QoL and one assessing symptoms of depression and anxiety. 
The perceived QoL was measured with two generic and widely used questionnaires, the Short 
Form-36 (SF-36) 
18
 and the EuroQoL-5 Dimension Questionnaire 
19
. The Hospital Anxiety 
and Depression Scale (HADS) 
20 
was used to detect self-rated symptoms of anxiety and 
depression. Higher scores indicated better QoL or more symptoms of depression or anxiety. 
The three questionnaires have been validated in a Swedish context 
21–23
.  
Sensitization was detected by quantitative sensory testing. This is a sensitive and 
formalized psychophysical test that quantifies the perception of pain by measuring the pain 
thresholds from many different body locations (in and outside painful areas). Thermal stimuli 
for heat and cold are usually combined with pressure stimuli 
24
.  
The pain thresholds were measured on six locations on the body: a) the medial plane of 
the low back just below the fifth lumbar vertebra, b) the abdominal wall, seven cm lateral to 
the umbilicus on both sides, c) just above the symphysis pubis, five cm lateral to the midline 
on both sides, and d) on the dominant leg, four cm distally from the tuberositas tibiae (Figure 
1). The sites a), b) and c) were assessed as the presumed referral areas of menstrual pain 
16,25
, 
and the site d) as the non-pain referral control area. 
Pain thresholds for heat and cold were measured using quantitative sensory testing with 
a Medoc TSA II NeuroSensory Analyzer (Medoc Ltd., Ramat Yishai, Israel). From a baseline 
of 32°C a computer-controlled thermode with a surface area of 3x3 cm
2
 was increased 
(maximum 50°C) or decreased (minimum 0°C) with a rate changing between 0.3°C/s and 
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4.0°C/s. On detection of the first painful stimulus, the participants mouse-clicked to stop the 
stimulation. The temperature of the thermode was registered by the computer as the threshold 
for heat or cold. The thermode then returned to the baseline temperature of 32°C. Three 
repeat measurements were performed on each location with an interval of 10 seconds. The 
average temperature of the three measurements of each stimuli was used in the calculations 
24
. 
For measuring pain pressure thresholds a hand-held electronic algometer (Sometic AB, 
Hornby, Sweden) with a probe area of 1 cm
2
 was used. The pressure was applied at a 
constant rate of approximately 40 kPa/s. The women were instructed to verbally indicate 
when the perceived sensation changed from pressure to pain, by saying “stop”. The 
measurement was repeated three times on each location with a 10-second pause between the 
measurements. The average of the three measurements was calculated and referred to as the 
pressure pain threshold 
24
. Eventually, the mean value for each modality (heat, cold and 
pressure) was calculated as the average of all locations and used in the analyses.  
The testing order of the three stimuli and the order of the locations on the body were 
altered randomly among the participants, but pain thresholds for cold were always 
determined before thresholds for heat, due to a pre-setting in the computer program. The 
measurements were performed by the first author and three female research nurses 
experienced in quantitative sensory testing.  
 
Statistical analyses 
 
Statistical analyses were conducted with the software Statistica v 13.1 (Dell Software, Aliso 
Viejo, CA, USA). Nominal data are presented as number and percentage. Continuous 
variables are described as mean, standard deviation and range.  
Comparisons of demographic data between the groups were made by univariate 
ANOVA and Bonferroni post hoc test for continuous variables and with a Chi-square test or 
Fisher’s exact test for categorical data. The level of statistical significance was set at p < 0.05. 
Crude differences between pain thresholds in the different groups were measured with a 
univariate ANOVA and a Bonferroni post hoc test. In order to adjust for known or potential 
confounding factors, a multivariate ANOVA was conducted, with age and smoking habits 
simultaneously added to the model as confounders. The Bonferroni post hoc tests were used 
to analyze the pairwise associations between groups.  
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Spearman’s rank-order correlation was used to measure the strength and direction of 
the assumed monotonic relationships between the means of pain thresholds for each stimulus 
(heat, cold and pressure), duration of pelvic pain, and the QoL regarding the specific 
subscales bodily pain and mental health in the SF-36, and level of anxiety and depression in 
the HADS, respectively. The Spearman’s rho (R) and the p-value, are presented. A positive R 
indicates a positive correlation and a negative R indicates a negative correlation. 
 
Ethical approval 
The study was approved by the Regional Ethics Board of Linköping University (Dnr 
2013/19-3). 
 
RESULTS 
A total of 92 women completed the study: 37 women with PPP and 55 healthy women in the 
reference group. Thirteen of the women with PPP were diagnosed (biopsy-proven) with 
endometriosis. The demographic and clinical characteristics of the participants are presented 
in Table 1. The women with PPP were significantly younger than the reference women were 
and had a lower parity but were more often smokers. 
The outcomes of the measurements of the pain thresholds are shown in Table 2. The 
thresholds are depicted for each location. The mean thresholds of all locations are illustrated 
in Figure 2. The women with PPP had significantly lower pain thresholds on all anatomical 
locations including the reference location (TT4D, dominant leg) for the three stimuli 
compared to the reference group. The post hoc tests showed unanimously that all women 
with PPP had highly significantly deviating pain thresholds compared with those of the 
reference group. No significant differences were observed in pain thresholds between the 
women who received a biopsy-proven endometriosis diagnosis (13 women) and those 
without endometriosis (24 women) in any of the locations or stimuli modalities. These results 
remained even when adjustments were made for the confounders of age and smoking habits, 
as shown by the adjusted p-values (Table 2). 
The correlations between the mean pain thresholds and the duration of pelvic pain were 
examined in the entire study group. The correlations were statistically significant for all three 
measured modalities of pain thresholds. (R = -0.28, p = 0.006 for heat, R = 0.27, p = 0.009 
for cold, and R = -0.34, p<0.001 for pressure, respectively). 
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The women with PPP rated their QoL significantly lower than the reference women in 
all dimensions of SF-36 and EuroQoL-5 Dimension Questionnaire, and scored significantly 
higher than the reference women for symptoms of anxiety and depression according to 
HADS (Table 3). Generally, no significant differences were found in any of the scales 
between the two subgroups of women with PPP (Table 3).  
The correlations between pain thresholds and the outcomes of QoL and HADS forms 
used the mean value for each pain stimulus modality. Among all the women with PPP, both 
heat and cold pain thresholds but not pressure thresholds were significantly correlated with 
the SF-36 dimension covering bodily pain (R = 0.45, p = 0.011 for heat, R = -0.56, p = 0.001 
for cold and R = 0.34, p = 0.059 for pressure, respectively). None of three pain stimuli 
modalities was significantly correlated with the SF-36 subscale mental health (data not 
shown). Only the cold pain threshold was also significantly correlated with the HADS 
subscale symptoms of depression (R=0.35, p=0.037).  
In the reference group, no significant correlations were found between any of the three 
stimuli modalities and the SF-36 subscales bodily pain or mental health or HADS (data not 
shown).  
 
DISCUSSION 
This study showed widespread alterations in pain thresholds in the women with PPP and 
symptoms of endometriosis, which is indicative of CS. The women with PPP had 
significantly lower pain thresholds for heat, cold and pressure compared with the reference 
group of healthy women. However, there were no statistically significant differences in pain 
thresholds between the  women with pain who had a confirmed diagnosis of endometriosis 
and those where no endometriosis was found, which highlights the effect of pain and not 
endometriosis per se in the development of this persistent pain state. The correlation analyses 
showed 1) that the duration of pelvic pain was associated with pain thresholds, and 2) the 
more pain the women experienced (SF-36 domain bodily pain), the more sensitive they were 
to cold and heat.  
Prolonged noxious physical or pathological stimuli in animal models leads to CS in 
which the central nervous system amplifies the perception of pain 
8
. Clinical signs as a proxy 
for CS can be measured by a general, widespread lowering of pain thresholds, as observed in 
the present study. Meanwhile, reduced pain thresholds in the painful area but not at the 
control site could also be due to peripheral sensitization. In endometriosis, the ectopic lesions 
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send noxious signals that are also consolidated by the inflammatory factors activated around 
the lesions 
26
. Stratton et al. showed that women with any history of endometriosis (past or 
present) had a higher proportion of sensitization compared with women with PPP only, and 
pain-free controls 
9
. Nonetheless, in accordance with Laursen et al. 
13
, our findings suggest 
that the reduced pain thresholds were not related to the presence of visible endometriosis 
lesions, but to the state of persistent pain. Thus, our findings support the “pain-focused” 
hypothesis where the persistent pain per se rather than the endometriosis contributes to the 
development of CS. 
The study revealed statistically significant correlations between the duration of pelvic 
pain and the pain thresholds, and thereby confirmed previous studies on other groups of 
chronic pain patients 
8
. To the best of our knowledge, this is the first study to show this 
correlation in women with pelvic pain. Our results thus support the previous suggestions that 
pain duration is a crucial factor in the development of sensitization 
27
. 
There are some limitations to this study. The cross-sectional design prevented us from 
determining whether the reduced pain thresholds were a cause or a consequence of the pain 
experience. The duration of pelvic pain was a subjective variable and may have been 
inaccurately remembered by the women, which constitutes a risk for recall bias. Since the 
referred area related to pelvic pain involves both the lower back and the abdominal wall, the 
points were selected bilaterally for assessing referred pain somatic hyperalgesia. Only one 
point outside those regions was selected for assessing the generalized CS.  
Four examiners conducted the quantitative sensory testing and might have informed the 
participants slightly differently or performed the pain pressure testing in different ways. The 
examiners were not blinded to group belonging (women with pelvic pain or controls), which 
might constitute a risk of expectation bias. Because of the equality in pain thresholds between 
the women with PPP and the relatively low number of individuals in the subgroups 
(endometriosis and no endometriosis), we decided to analyze them as one group in the 
correlation analyses.  
 
 
Since the effect size in pain thresholds was unknown and the study has an exploratory 
character, we did not conduct an a priori power analysis but based our sample size on the 
scanty materials that have been presented in the literature for similar groups of patients 
10,11,13
. The generalizability of the results may be limited due to the relatively small sample 
size. Interpretation should therefore be carried out with caution. Nevertheless, the results 
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contribute new information covering the combination of the three pain stimuli modalities and 
the unanimous outcomes in results of pain thresholds in women with PPP and suspicion of 
endometriosis.  
In clinical praxis, alleviating pain is the major goal in the medical and surgical 
therapies of endometriosis for several reasons. The consequence of persistent pain in the 
development of CS emphasizes that endometriosis and symptoms indicating endometriosis 
might benefit from being treated actively and perhaps more aggressively from the beginning 
when the woman seek medical care. This might, in accordance with our findings of a time-
dependent association between duration of pain and reduced pain thresholds, prevent or at 
least minimize the development of a state that may cause severe human suffering and reduced 
QoL. A comprehensive schedule for investigation and treatment with a multi-disciplinary 
approach should be followed. If the traditional treatment for suspected endometriosis does 
not soon alleviate the symptoms, the diagnosis should be re-considered, and invasive 
diagnostic tools should be employed to verify the diagnosis. The treatment should then be 
focused on both the specific disease and proper management of the pain condition. The 
“disease-focused” vs. the “pain-focused” mechanisms behind the consequences of 
endometriosis pain have been described previously but need further illumination 
4,5,12
.  
 
CONCLUSION 
 
Women with PPP, with or without proven endometriosis, showed similar widespread 
alterations in pain thresholds with significantly reduced pain thresholds compared with a 
reference group of healthy women. These findings suggest that CS may be a general feature 
in women with PPP and it seems unrelated to the presence of endometriosis per se, but the 
duration (although assessed in a cross-sectional design) of the pain state might be a driving 
force in the development of sensitization. 
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Legends to Figures 
 
Figure 1. The six locations on the body where the quantitative sensory testing was performed. 
a) the medial plane of the low back just below the fifth lumbar vertebra, b) the abdominal 
wall seven cm lateral to the umbilicus on both sides, c) just above the symphysis pubis, five 
cm lateral to the midline on both sides, and d) on the dominant leg, four cm distally from the 
tuberositas tibiae. 
 
Figure 2. Mean heat, cold and pressure pain thresholds. A= PPP and endometriosis; B = PPP 
and no endometriosis; C= control. PPP = persistent pelvic pain. Plots indicate mean pain 
thresholds and bars present 95% confidence interval. * adjusted for age and smoking habits. 
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Table 1. Demographic and clinical characteristics of women with persistent pelvic pain with or without a biopsy-proven endometriosis diagnosis 
and of healthy reference women. 
 
 Women with persistent pelvic pain and: 
Reference group 
of healthy women  Post hoc tests 
Variable 
biopsy-proven 
endometriosis 
(Group A; n=13) 
no endometriosis 
(Group B; n=24) (Group C; n=55) p-value 
A vs. B 
p-value 
A vs. C 
p-value 
B vs. C 
p-value 
Age (years) 26.2±6.4;19-40 26.6±5.7;18-39 30.2±5.6;18-40 0.010a >0.999b 0.073 b 0.034 b 
Parity (no. of deliveries) 0.4±0.96;0-3 0.4±0.82;0-3 1.1±1.2;0-5 0.005 a >0.999 b 0.074 b 0.013 b 
BMI (kg/m2) 25.1±5.8;17.8-33.4 24.2±4.2;19.0-31.9 24.2±3.8;18.4-34.6 0.844 a    
Currently smoking (no. of women)  4 (30.8) 5 (20.8) 2 (3.6) 0.008c 0.691d 0.010d 0.024d 
Current use of type of contraception (no. of women)        
None 8 (61.5) 9 (37.5) 21 (38.2) 0.164c    
Combined oestrogen/progestin  1 (7.7) 10 (41.6) 14 (25.5) 
 
   
Progestin only 4 (30.8) 5 (20.8) 20 (36.4)    
Current use of analgesics (no. of women)        
None 
 
8 (61.5) 12 (50.0)      
Paracetamol 1 (7.7) 2 (8.3)      
NSAID and paracetamol 0 (0.0) 4 (16.7)      
NSAID 2 (15.4) 4 (16.7)      
Mild opioids and paracetamol 0 (0) 1 (4.2)      
Opioids 2 (15.4) 1 (4.2)      
rASRM classification of endometriosis (no. of women)        
Minimal 
Mild 
 
8 (61.5)       
Mild 1 (7.7)       
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Moderate 3 (23.1)       
Severe 1 (7.7)       
Duration of pelvic pain (months) 56.6.±48.2;6-144  47.4±43.1;4-162 -- 0.556a    
 
Figures denote mean and ±SD; range, or number of women and (%). BMI – body mass index. NSAID – non-steroidal anti-inflammatory drugs. rASRM - revised American 
Society for Reproductive Medicine. 
a
ANOVA;  
b
Bonferroni, 
c
χ
2
 test for trends. 
d
Fischers exact test 
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Table 2. Pain thresholds for heat (
o
C), cold (
o
C), and pressure (kPa) in women with persistent pelvic pain with or without a biopsy-proven 
endometriosis diagnosis and in healthy reference women.  
 
 
 
 
 
 
 
 
HEAT (oC) Women with 
persistent pelvic pain and: 
Reference group 
of healthy 
women  ANOVA Bonferroni post hoc test 
Location 
biopsy-proven 
endometriosis 
(Group A; n=13)  
no 
endometriosis 
(Group B; n=24)   (Group C; n=55)   p-value 
A vs. B 
p-value 
A vs. C 
p-value 
B vs. C 
p-value 
L5 43.6±4.2 43.6±4.5 47.2±2.7 
Crude <0.001 >0.999 0.003 <0.001 
Adjusted a <0.001 >0.999 0.002 <0.001 
Abd U7R 45.1±4.0 43.9±3.9 47.8±2.1 
Crude <0.001 0.803 0.012 <0.001 
Adjusted a <0.001 0.814 0.013 <0.001 
Abd U7L 44.0±4.6 43.5±4.2 47.6±2.3 
Crude <0.001 >0.999 0.002 <0.001 
Adjusted a <0.001 >0.999 0.002 <0.001 
ASP5R 44.6.0±4.1 43.6±3.9 47.5±2.4 
Crude <0.001 >0.999 0.009 <0.001 
Adjusted a <0.001 >0.999 0.010 <0.001 
ASP5L 43.9±4.7 43.3±4.3 47.5±2.4 
Crude <0.001 >0.999 0.002 <0.001 
Adjusted a <0.001 >0.999 0.002 <0.001 
TT4D 44.7±4.5 44.4±3.4 47.6±2.2 
Crude <0.001 >0.999 0.005 <0.001 
Adjusted a <0.001 >0.999 0.005 <0.001 
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Table 2 continued.  
 
 
 
 
 
 
 
COLD (oC) 
Women with 
persistent pelvic pain and: 
Reference group of 
healthy women  ANOVA Bonferroni post hoc test 
Location 
biopsy-proven 
endometriosis 
(Group A; n=13)  
no endometriosis 
(Group B; n=24)   (Group C; n=55)   p-value 
A vs. B 
p-value 
A vs. C 
p-value 
B vs. C 
p-value 
L5 12.1±10.3 14.3±11.6 3.8±7.7 
Crude <0.001 >0.999 0.014 <0.001 
Adjusted a <0.001 >0.999 0.013 <0.001 
Abd U7R 12.3±9.9 10.5±9.4 3.0±6.3 
Crude <0.001 >0.999 0.001 <0.001 
Adjusted a <0.001 >0.999 0.001 <0.001 
Abd U7L 13.5±10.3 13.6±10.1 3.8±7.2 
Crude <0.001 >0.999 0.001 <0.001 
Adjusted a <0.001 >0.999 0.001 <0.001 
ASP5R 15.9±10.4 15.9±11.0 6.4±9.1 
Crude <0.001 >0.999 0.007 <0.001 
Adjusted a <0.001 >0.999 0.007 <0.001 
ASP5L 15.6±10.0 16.9±10.6 4.9±8.3 
Crude <0.001 >0.999 0.001 <0.001 
Adjusted a <0.001 >0.999 0.001 <0.001 
TT4D 6.8±9.6 8.4±9.6 1.4±4.1 
Crude <0.001 >0.999 0.035 <0.001 
Adjusted a <0.001 >0.999 0.033 <0.001 
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Table 2 continued.  
 
 
 
 
 
PRESSURE (kPa) 
Women with  
persistent pelvic pain and: 
Reference group  
of healthy women  ANOVA Bonferroni post hoc test 
Location 
biopsy-proven 
endometriosis 
(Group A; n=13)  
no endometriosis 
(Group B; n=24)   (Group C; n=55)   p-value 
A vs. B 
p-value 
A vs. C 
p-value 
B vs. C 
p-value 
L5 524.7±318.5. 498.1±318.5 815.0±334.2 
Crude <0.001 >0.999 0.014 <0.001 
Adjusted a 0.001 >0.999 0.016 <0.001 
Abd U7R 237.4±85.6 255.2±167.1 435.8±179.5 
Crude <0.001 >0.999 0.001 <0.001 
Adjusted a  <0.001 >0.999 0.001 <0.001 
Abd U7L 250.3±106.7 231.7±134.9 439.8±184.6 
Crude <0.001 >0.999 0.001 <0.001 
Adjusted a  <0.001 >0.999 0.001 <0.001 
ASP5R 228.9±80.1 202.8±104.2 403.3±138.8 
Crude <0.001 >0.999 <0.001 <0.001 
Adjusted a  <0.001 >0.999 <0.001 <0.001 
ASP5L 233.4±84.2 210.3±114.3 389.9±135.5 
Crude <0.001 >0.999 <0.001 <0.001 
Adjusted a  <0.001 >0.999 0.001 <0.001 
TT4D 610.5±300.1 476.1±195.3 809.0±271.1 
Crude <0.001 0.402 0.043 <0.001 
Adjusted a  <0.001 0.409 0.045 <0.001 
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Figures denote means ± one standard deviation. a Adjusted for age and smoking.  
 
Location: L5 – back, over L5; Abd U7R – abdominal wall, 7 cm right of umbilicus; Abd U7L – abdominal wall, 7 cm left of umbilicus; ASP5R – above symphysis pubis, 5 
cm right of midline; ASP5L – above symphysis pubis, 5 cm left of midline; TT4D – 4 cm distal of tuberositas tibiae of dominant leg. 
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Table 3. Outcome of quality of life (SF-36, EQ-5D-3L) and anxiety and depression (HADS) in women with persistent pelvic pain with or 
without a biopsy-proven endometriosis diagnosis and in healthy reference women. 
 
 
 
Women with  
persistent pelvic pain and: 
Reference group 
of healthy women ANOVA Bonferroni post hoc test 
Form/subscale 
biopsy-proven 
endometriosis 
(Group A; n=13)  
no endometriosis 
(Group B; n=24)   (Group C; n=55)  p-value 
A vs. B 
p-value 
A vs. C 
p-value 
B vs. C 
p-value 
 SF-36 Physical functioning 78.1±26.8 78.3±21.0 98.9±3.5 <0.001 >0.999 <0.001 <0.001 
Role limitation physical 28.9±26.7 25.0±35.4 98.6±5.7 <0.001 >0.999 <0.001 <0.001 
Bodily pain 33.1±13.6 41.4±20.9 85.3±18.6 <0.001 0.651 <0.001 <0.001 
General health 42.5±25.5 42.1±20.0 83.7±14.7 <0.001 >0.999 <0.001 <0.001 
Vitality 28.5±22.1 33.1±23.7 65.7±17.6 <0.001 >0.999 <0.001 <0.001 
Social functioning 52.9±22.3 40.3±20.4 92.6±13.7 <0.001 0.135 <0.001 <0.001 
Role limitation emotional 35.9±44.0 42.0±44.0 93.8±19.5 <0.001 >0.999 <0.001 <0.001 
Mental health  45.5±22.1 40.9±18.4 81.0±13.9 <0.001 >0.999 <0.001 <0.001 
Physical component summary 39.4±7.7 41.2±9.3 55.5±3.6 <0.001 >0.999 <0.001 <0.001 
Mental component summary  29.4±13.1 26.3±11.4 48.8±8.7 <0.001 >0.999 <0.001 <0.001 
 EQ-5D-3L Health state index 0.49±0.32 0.46±0.32 0.95±0.11 <0.001 >0.999 <0.001 <0.001 
HADS Anxiety 9.4±5.4 10.1±3.7 4.6±3.4 <0.001 >0.999 <0.001 <0.001 
Depression 8.1±4.6 7.7±4.2 2.3±2.4 <0.001 >0.999 <0.001 <0.001 
 
 
Figures denote means ± one standard deviation.  
SF-36, Short Form Health Survey 36; EQ-5D-3L, EuroQoL-5 Dimension Questionnaire; HADS – Hospital Anxiety and Depression Scale.  
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